Evidence map›Paper›PMID 22941779›Full record

ArticleJournal of tissue engineering and regenerative medicine2012

Adeno-associated virus-coated allografts: a novel approach for cranioplasty.

Ayelet Ben Arav, Gadi Pelled, Yoram Zilberman, Nadav Kimelman-Bleich, Zulma Gazit, Edward M Schwarz, Dan Gazit

Open access · greenAbstract read
In one paragraph

Article in Journal of tissue engineering and regenerative medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ayelet Ben AravSkeletal Biotech Laboratory, Hebrew University-Hadassah Faculty of Dental Medicine, Ein Kerem, Jerusalem, Israel.
Gadi Pelled
Yoram Zilberman
Nadav Kimelman-Bleich
Zulma Gazit
Edward M Schwarz
Dan Gazit
Hebrew University of Jerusalem · ILCedars-Sinai Medical Center · USUniversity of Rochester Medical Center · US

Funding

Translating PTH Therapy as an Adjuvant for Structural AllograftingP50AR054041 · NIAMS · UNIVERSITY OF ROCHESTER · PI O'KEEFE, REGIS J · 2006 to 2016
$15.7M
PTH Effects of Craniofacial AllograftsR01DE019902 · NIDCR · UNIVERSITY OF ROCHESTER · PI GAZIT, DAN, SCHWARZ, EDWARD M. · 2009 to 2019
$5.0M
Prostaglandin Signaling in Wear Debris-induced OsteolysisR01AR046545 · NIAMS · UNIVERSITY OF ROCHESTER · PI O'KEEFE, REGIS J · 2000 to 2009
$3.0M
The University of Rochester Core Center for Musculoskeletal Biology and MedicineP30AR061307 · NIAMS · UNIVERSITY OF ROCHESTER · PI SCHWARZ, EDWARD M. · 2011 to 2015
$3.0M
Revitalizing Allografts for Craniofacial ReconstructionR21DE017096 · NIDCR · UNIVERSITY OF ROCHESTER · PI SCHWARZ, EDWARD M. · 2006 to 2007
$331k
NIAMS NIH HHS P30 AR061307NIAMS NIH HHS P30 AR061307-01NIAMS NIH HHS P50 AR054041NIAMS NIH HHS P50 AR054041-06NIAMS NIH HHS R01 AR046545NIDCR NIH HHS R01 DE019902NIDCR NIH HHS R01 DE019902-01NIDCR NIH HHS R01 DE019902-02NIDCR NIH HHS R01 DE019902-03NIDCR NIH HHS R21 DE017096PHS HHS R21 DEO17096
6 · The paper itself

Abstract

Bone autografts are considered the gold standard for cranioplasty, although they lead to co-morbidity. Bone allografts are more easily obtained but have low osteogenic potential and fail to integrate into healthy bone. Previously, we showed that, by coating long-bone allografts with freeze-dried recombinant adeno-associated virus (rAAV) vector encoding for an osteogenic gene, enhanced osteogenesis and bone integration were achieved. In this study our aim was to evaluate the bone repair potential of calvarial autografts and allografts coated with either single-stranded rAAV2 vector (SS-rAAV-BMP2) or self-complementary pseudotyped vector (SC-rAAV-BMP2) encoding for bone morphogenetic protein (BMP)2 in a murine cranioplasty model. The grafts were implanted into critical defects in the calvariae of osteocalcin/luciferase (Oc/Luc) transgenic mice, which allowed longitudinal monitoring of osteogenic activity using bioluminescence imaging (BLI). Our results showed that the bioluminescent signal of the SC-rAAV-BMP2-coated allografts was 40% greater than that of the SS-rAAV-BMP2-coated allografts (p<0.05) and that the bioluminescent signal of the SS-rAAV-BMP2-coated allografts was not significantly different from the signals of the autografts or uncoated allografts. Micro-computed tomography (μCT) confirmed the significant increase in osteogenesis in the SC-rAAV-BMP2 group compared with the SS-rAAV-BMP2 group (p<0.05), indicating a significant difference in bone formation when compared with the other grafts tested. In addition, histological analysis revealed extensive remodelling of the autografts. Collectively, these results demonstrate the feasibility of craniofacial regeneration using SC-rAAV-BMP2-coated allografts, which may be an attractive therapeutic solution for repair of severe craniofacial bone defects.

Indexed as

Bone RegenerationBone TransplantationDependovirusGenetic VectorsOsteogenesisAnimalsBone Morphogenetic Protein 2FemaleMiceMice, TransgenicPlastic Surgery ProceduresTransplantation, HomologousBmp2 protein, mouseBone Morphogenetic Protein 2

Identifiers

PMID22941779
PMCPMC3652248
OpenAlexW2098464328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.